i 123 MIBGmeta iodobenzylguanidine (AnazaoHealth Corporation)
Welcome to the PulseAid listing for the i 123 MIBG drug offered from AnazaoHealth Corporation. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | AnazaoHealth Corporation |
NON-PROPRIETARY NAME: | i 123 MIBG |
SUBSTANCE NAME: | IOBENGUANE SULFATE I-123 |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
MARKETING CATEGORY NAME: | UNAPPROVED DRUG OTHER |
START MARKETING DATE: | 2012-05-23 |
END MARKETING DATE: | 0000-00-00 |
i 123 MIBG meta iodobenzylguanidine HUMAN PRESCRIPTION DRUG Details:
Item Description | i 123 MIBG meta iodobenzylguanidine from AnazaoHealth Corporation |
LABELER NAME: | AnazaoHealth Corporation |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 25(mCi/1) |
START MARKETING DATE: | 2012-05-23 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 51808-103_ea9f7125-98b5-49c3-85b8-763915156ff0 |
PRODUCT NDC: | 51808-103 |
APPLICATION NUMBER: | |
Other IOBENGUANE SULFATE I-123 Pharmaceutical Manufacturers / Labelers: